Stefan Carlsson

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

Andreas Kindmark, A Jawaid, Chris Harbron et al. · The Pharmacogenomics Journal · 2007 · 365 citations

Genetic Epidemiology, Immunology, Pathology +17

The Direct Thrombin Inhibitor Melagatran and Its Oral Prodrug H 376/95: Intestinal Absorption Properties, Biochemical and Pharmacodynamic Effects

David Gustafsson, Jan-Erik Nyström, Stefan Carlsson et al. · Thrombosis Research · 2001 · 302 citations

Pharmaceutical Science, Biochemistry, Medicine +5

Antithrombotic Effects and Bleeding Time of Thrombin Inhibitors and Warfarin in the Rat

Margareta Elg, David Gustafsson, Stefan Carlsson · Thrombosis Research · 1999 · 116 citations

Thrombosis, Thrombin Inhibitors, Cardiovascular Disease +13

Effect of Activated Prothrombin Complex Concentrate or Recombinant Factor VIIa on the Bleeding Time and Thrombus Formation During Anticoagulation with a Direct Thrombin Inhibitor

Margareta Elg, Stefan Carlsson, David Gustafsson · Thrombosis Research · 2001 · 105 citations

Thrombosis, Cardiovascular Disease, Bleeding Time +11

Antithrombotic Effect of Two Low Molecular Weight Thrombin Inhibitors and a Low-Molecular Weight Heparin in a Caval Vein Thrombosis Model in the Rat

Bengt I. Eriksson, Stefan Carlsson, Margit Halvarsson et al. · Thrombosis and Haemostasis · 1997 · 71 citations

Pharmacotherapy, Antithrombotic Effect, Thrombosis +19